Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Human Immunodeficiency Virus | Research

Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with /or at risk of Kaposi disease in Yaounde

Authors: Roger Ahouga Voufo, Armand Emmanuel Kouotou, Nchinda Jones Tatah, Georges TeTo, Cédric Gueguim, Chantal Marie Essome Ngondé, Armand Gabin Njiguet Tepa, Arnaud Gabin, Falmata Amazia, Natacha Lena Yembeau, Charles Kouanfack, Pieme Constant Anatole

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Objective

To investigate the relation between interleukin-6 concentration and oxidative status of HIV infected patients with or at risk of Kaposi’s disease in Yaoundé.

Methods

We conducted a two-months cross-sectional study on 87 consenting HIV infected patients followed at the Day Hospital of the Yaoundé Central Hospital. Serum/plasma obtained after centrifugation of blood collected in dry/EDTA tubes was used for the determination of Human Herpes Virus-8 antigen (HHV-8) and Interleukin-6 (IL-6) by the ELISA technique, and that of oxidative stress markers: Malondialdehyde (MDA) reduced Glutathione (GSH) and total antioxidant capacity by spectrophotometry.

Results

Subjects belonging to the [40–50[year-old age group were mainly represented in our study population with 43.7%. The average age was 44.6 ± 10.4 years with extremes ranging from 26 to 72 years. The sex ratio was 0.24. Our population was mainly represented by people infected with HIV type I (90.8%) and 3.4% had developed clinical signs of Kaposi’s disease. The prevalence of the HHV-8 antigen was 57.5%. Immune and oxidative parameters did not vary with age, sex and therapeutic line. We noted a significant increase in IL-6 concentrations in patients positive to the HHV-8 antigen for IL-6 concentrations < 37 (P = 0.005; CI= [0.40; 0.59]. MDA and GSH concentrations increased significantly with the HHV-8 infection (P < 0.0001; CI= [0.40; 0.59] and P < 0.0001; CI= [13.30;21.45], respectively). Total antioxidant capacity (FRAP) decreased significantly with HHV-8 infection (P = 0.004; CI= [-69.18; -13.78]). We noted a significant increase in MDA concentrations in patients taking their ARVs irregularly, (P < 0.0001).

Conclusion

Our study showed a weak positive correlation between IL-6 and MDA, a strong negative correlation between FRAP and MDA and a strong positive correlation between MDA and GSH highlighting the association of these few markers of oxidative stress and Il-6 to the risk of Kaposi’s disease.
Literature
1.
go back to reference Radu O, Pantanowitz L. Kaposi Sarcoma. Arch Pathol Lab Mesd 31 janv. 2013;137(2):289–94.CrossRef Radu O, Pantanowitz L. Kaposi Sarcoma. Arch Pathol Lab Mesd 31 janv. 2013;137(2):289–94.CrossRef
2.
go back to reference Schneider JW, Dittmer DP. Diagnosis and treatment of Kaposi Sarcoma. Am J Clin Dermatol août. 2017;18(4):529–39.CrossRef Schneider JW, Dittmer DP. Diagnosis and treatment of Kaposi Sarcoma. Am J Clin Dermatol août. 2017;18(4):529–39.CrossRef
3.
go back to reference Boué F, Lebbé C. Le sarcome de Kaposi. Bull Cancer (Paris). 2003;90(5):393–8.PubMed Boué F, Lebbé C. Le sarcome de Kaposi. Bull Cancer (Paris). 2003;90(5):393–8.PubMed
4.
go back to reference Aubry PP. Maladie de Kaposi Actualités 2019.:5. Aubry PP. Maladie de Kaposi Actualités 2019.:5.
6.
go back to reference Cappetta D, De Angelis A, Sapio L, Prezioso L, Illiano M, Quaini F, et al. Oxidative stress and Cellular Response to Doxorubicin: a common factor in the Complex Milieu of Anthracycline Cardiotoxicity. Oxid Med Cell Longev. 2017;2017:1521020.CrossRefPubMedPubMedCentral Cappetta D, De Angelis A, Sapio L, Prezioso L, Illiano M, Quaini F, et al. Oxidative stress and Cellular Response to Doxorubicin: a common factor in the Complex Milieu of Anthracycline Cardiotoxicity. Oxid Med Cell Longev. 2017;2017:1521020.CrossRefPubMedPubMedCentral
7.
go back to reference Yan L, Majerciak V, Zheng Z-M, Lan K. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis. Virol Sin. avr 2019;34(2):135–61. Yan L, Majerciak V, Zheng Z-M, Lan K. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis. Virol Sin. avr 2019;34(2):135–61.
8.
go back to reference Williams AA, Sitole LJ, Meyer D. HIV/HAART-associated oxidative stress is detectable by metabonomics. Mol Biosyst 24 oct. 2017;13(11):2202–17.CrossRef Williams AA, Sitole LJ, Meyer D. HIV/HAART-associated oxidative stress is detectable by metabonomics. Mol Biosyst 24 oct. 2017;13(11):2202–17.CrossRef
9.
go back to reference Ivanov AV, Valuev-Elliston VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B, et al. Oxidative stress during HIV infection: mechanisms and consequences. Oxid Med Cell Longev. 2016;2016:8910396.CrossRefPubMedPubMedCentral Ivanov AV, Valuev-Elliston VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B, et al. Oxidative stress during HIV infection: mechanisms and consequences. Oxid Med Cell Longev. 2016;2016:8910396.CrossRefPubMedPubMedCentral
10.
go back to reference Cornejo Castro EM, Morrison BJ, Marshall VA, Labo N, Miley WJ, Clements N, et al. Relationship between human leukocyte antigen alleles and risk of Kaposi’s sarcoma in Cameroon. Genes Immun. 2019;20(8):684–9.CrossRefPubMedPubMedCentral Cornejo Castro EM, Morrison BJ, Marshall VA, Labo N, Miley WJ, Clements N, et al. Relationship between human leukocyte antigen alleles and risk of Kaposi’s sarcoma in Cameroon. Genes Immun. 2019;20(8):684–9.CrossRefPubMedPubMedCentral
14.
go back to reference Helle M, Boeije L, de Groot E, de Vos A, Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 8 avr. 1991;138(1):47–56.CrossRef Helle M, Boeije L, de Groot E, de Vos A, Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 8 avr. 1991;138(1):47–56.CrossRef
15.
go back to reference Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med avr. 1976;15(2):212–6.CrossRef Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med avr. 1976;15(2):212–6.CrossRef
16.
go back to reference Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of « antioxidant power »: the FRAP assay. Anal Biochem 15 juill. 1996;239(1):70–6.CrossRef Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of « antioxidant power »: the FRAP assay. Anal Biochem 15 juill. 1996;239(1):70–6.CrossRef
17.
go back to reference Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys mai. 1959;82(1):70–7.CrossRef Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys mai. 1959;82(1):70–7.CrossRef
19.
go back to reference Mbondji-Wonje C, Ragupathy V, Lee S, Wood O, Awazi B, Hewlett IK. Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon. Viruses 19 sept. 2013;5(9):2253–9.CrossRef Mbondji-Wonje C, Ragupathy V, Lee S, Wood O, Awazi B, Hewlett IK. Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in Cameroon. Viruses 19 sept. 2013;5(9):2253–9.CrossRef
20.
go back to reference Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, et al. Plasma viral miRNAs indicate a high prevalence of Occult viral infections. EBioMedicine juin. 2017;20:182–92.CrossRef Fuentes-Mattei E, Giza DE, Shimizu M, Ivan C, Manning JT, Tudor S, et al. Plasma viral miRNAs indicate a high prevalence of Occult viral infections. EBioMedicine juin. 2017;20:182–92.CrossRef
21.
go back to reference Taieb F. Accès à la charge virale pour les patients infectés par le VIH sous traitement antiretrovirn zone décentralisée des pays à niveau de ressources faible ou modéré.:139. Taieb F. Accès à la charge virale pour les patients infectés par le VIH sous traitement antiretrovirn zone décentralisée des pays à niveau de ressources faible ou modéré.:139.
23.
go back to reference Thorin-Trescases N, Voghel G, Farhat N, Drouin A, Gendron M-È, Thorin É. Âge et stress oxydant: vers un déséquilibre irréversible de l’homéostasie endothéliale. Med Sci MS oct. 2010;26(10):875–80. Thorin-Trescases N, Voghel G, Farhat N, Drouin A, Gendron M-È, Thorin É. Âge et stress oxydant: vers un déséquilibre irréversible de l’homéostasie endothéliale. Med Sci MS oct. 2010;26(10):875–80.
24.
go back to reference Gammoudi I, Khelil S, Dandana A, Jaidane Z, Chalghoum A, Noichri Y, et al. Étude des marqueurs du stress oxydatif chez les coronariens tabagiques tunisiens. Immuno-Anal Biol Spec - IMMUNO-ANAL BIOL SPEC. 1 juin. 2010;25:135–9. Gammoudi I, Khelil S, Dandana A, Jaidane Z, Chalghoum A, Noichri Y, et al. Étude des marqueurs du stress oxydatif chez les coronariens tabagiques tunisiens. Immuno-Anal Biol Spec - IMMUNO-ANAL BIOL SPEC. 1 juin. 2010;25:135–9.
25.
go back to reference Martinez V. Virus herpès humain 8 et maladie de Kaposi au cours de l’infection par le VIH : interactions et impact des traitements antirétroviraux - Human herpesvirus 8 and AIDS-associated Kaposi’s sarcoma: interaction and impact of antiretroviral therapy. Volume 5. M ISE AU POINT; 2005. Martinez V. Virus herpès humain 8 et maladie de Kaposi au cours de l’infection par le VIH : interactions et impact des traitements antirétroviraux - Human herpesvirus 8 and AIDS-associated Kaposi’s sarcoma: interaction and impact of antiretroviral therapy. Volume 5. M ISE AU POINT; 2005.
26.
go back to reference Éric KI, Michel BE, David MK, Athy KK, Julien IN, Anzwal L et al. Stress oxydatif et dommage sur le DNA au cours de l’infection à VIH, Rôle du Yaourt Probiotique dans la prévention.:6. Éric KI, Michel BE, David MK, Athy KK, Julien IN, Anzwal L et al. Stress oxydatif et dommage sur le DNA au cours de l’infection à VIH, Rôle du Yaourt Probiotique dans la prévention.:6.
27.
go back to reference Teto G, Kanmogne GD, Torimiro JN, Alemnji G, Nguemaim FN, Takou D et al. Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon. PLOS ONE. 7 juin 2013;8(6):e65126. Teto G, Kanmogne GD, Torimiro JN, Alemnji G, Nguemaim FN, Takou D et al. Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon. PLOS ONE. 7 juin 2013;8(6):e65126.
28.
go back to reference Watanabe LM, Barbosa Júnior F, Jordão AA, Navarro AM. Influence of HIV infection and the use of antiretroviral therapy on selenium and selenomethionine concentrations and antioxidant protection. Nutr Burbank Los Angel Cty Calif déc. 2016;32(11–12):1238–42.CrossRef Watanabe LM, Barbosa Júnior F, Jordão AA, Navarro AM. Influence of HIV infection and the use of antiretroviral therapy on selenium and selenomethionine concentrations and antioxidant protection. Nutr Burbank Los Angel Cty Calif déc. 2016;32(11–12):1238–42.CrossRef
Metadata
Title
Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with /or at risk of Kaposi disease in Yaounde
Authors
Roger Ahouga Voufo
Armand Emmanuel Kouotou
Nchinda Jones Tatah
Georges TeTo
Cédric Gueguim
Chantal Marie Essome Ngondé
Armand Gabin Njiguet Tepa
Arnaud Gabin
Falmata Amazia
Natacha Lena Yembeau
Charles Kouanfack
Pieme Constant Anatole
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02109-9

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.